Following the response induced by chemotherapeutic agents in breast cancer cells, both DOX and PTX promoted the expression of EZH2 and STAT3 at 48 h after 4 h of drug treatment (Fig. 6a). The gene discussed is EZH2; the disease is breast carcinoma.